340 related articles for article (PubMed ID: 1571896)
1. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
Lage JM; Weinberg DS; Huettner PC; Mark SD
Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
[TBL] [Abstract][Full Text] [Related]
2. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
Friedlander ML; Hedley DW; Swanson C; Russell P
J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
5. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
[TBL] [Abstract][Full Text] [Related]
6. Cellular DNA content and survival in advanced ovarian carcinoma.
Pfisterer J; Kommoss F; Sauerbrei W; Renz H; du Bois A; Kiechle-Schwarz M; Pfleiderer A
Cancer; 1994 Nov; 74(9):2509-15. PubMed ID: 7923008
[TBL] [Abstract][Full Text] [Related]
7. Ploidy assessment of benign and malignant ovarian tumors by flow cytometry. A clinicopathologic study.
Iversen OE; Skaarland E
Cancer; 1987 Jul; 60(1):82-7. PubMed ID: 3581034
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
[TBL] [Abstract][Full Text] [Related]
9. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: a prospective study.
Kaern J; Tropé CG; Kristensen GB; Tveit KM; Pettersen EO
Am J Obstet Gynecol; 1994 Feb; 170(2):479-87. PubMed ID: 8116701
[TBL] [Abstract][Full Text] [Related]
11. Flow and image cytometric DNA ploidy, including 5c exceeding cells, of serous borderline malignant ovarian tumors. Correlation with clinicopathologic characteristics.
Flezar MS; But I; Kavalar R; Us-Krasovec M
Anal Quant Cytol Histol; 2003 Jun; 25(3):139-45. PubMed ID: 12882085
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma.
Nordal RR; Kristensen GB; Kaern J; Stenwig AE; Pettersen EO; Tropé CG
Acta Oncol; 1995; 34(6):797-802. PubMed ID: 7576748
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinoma.
Pinto AE; Chaves P; Fidalgo P; Oliveira AG; Leitão CN; Soares J
Dis Colon Rectum; 1997 Apr; 40(4):411-9. PubMed ID: 9106689
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
15. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
Meyer JS; Gersell DJ; Yim S
Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
[TBL] [Abstract][Full Text] [Related]
16. Multivariate analysis of DNA ploidy, steroid hormone receptors, and CA 125 as prognostic factors in ovarian carcinoma: a prospective study.
Eissa S; Khalifa A; Laban M; Mohamed MK; Elian A
Nutrition; 1995; 11(5 Suppl):622-6. PubMed ID: 8748237
[TBL] [Abstract][Full Text] [Related]
17. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study.
al-Abadi H; Nagel R
J Urol; 1992 Jul; 148(1):31-7. PubMed ID: 1613875
[TBL] [Abstract][Full Text] [Related]
18. Tumor DNA ploidy and prognosis of patients with serous cystadenocarcinoma of the ovary.
Kigawa J; Minagawa Y; Ishihara H; Kanamori Y; Terakawa N
Cancer; 1993 Aug; 72(3):804-8. PubMed ID: 8334634
[TBL] [Abstract][Full Text] [Related]
19. Effect of cellular DNA content on the prognosis of epithelial ovarian cancers.
Ozalp S; Yalcin OT; Gulbas Z; Tanir HM; Minsin T
Gynecol Obstet Invest; 2001; 52(2):93-7. PubMed ID: 11586035
[TBL] [Abstract][Full Text] [Related]
20. [DNA ploidy and results of first line chemotherapy in ovarian cancer patients].
Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
Ginekol Pol; 2006 Aug; 77(8):589-96. PubMed ID: 17076189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
